The Potential Role of Bacteriophages in the Treatment of Recalcitrant Chronic Rhinosinusitis

被引:8
作者
Uyttebroek, Saartje [1 ,2 ]
Onsea, Jolien [3 ,4 ]
Metsemakers, Willem-Jan [3 ,4 ]
Dupont, Lieven [5 ,6 ]
Devolder, David [7 ]
Wagemans, Jeroen [8 ]
Lavigne, Rob [8 ]
Spriet, Isabel [7 ,9 ]
Van Gerven, Laura [1 ,2 ,10 ]
机构
[1] UZ Leuven, Dept Otorhinolaryngol, B-3000 Leuven, Belgium
[2] Katholieke Univ Leuven, Dept Neurosci, Expt Otorhinolaryngol, Rhinol Res, B-3000 Leuven, Belgium
[3] UZ Leuven, Dept Trauma Surg, B-3000 Leuven, Belgium
[4] Katholieke Univ Leuven, Dept Dev & Regenerat, Locomotor & Neurol Disorders, B-3000 Leuven, Belgium
[5] UZ Leuven, Dept Pneumol, B-3000 Leuven, Belgium
[6] Katholieke Univ Leuven, Dept Chron Dis & Metab, Resp Dis & Thorac Surg, B-3000 Leuven, Belgium
[7] UZ Leuven, Pharm Dept, B-3000 Leuven, Belgium
[8] Katholieke Univ Leuven, Lab Gene Technol, Dept Biosyst, B-3000 Leuven, Belgium
[9] Katholieke Univ Leuven, Dept Pharmaceut & Pharmacol Sci, Clin Pharmacol & Pharmacotherapy, B-3000 Leuven, Belgium
[10] Katholieke Univ Leuven, Allergy & Clin Immunol Res Unit, Dept Microbiol Immunol & Transplantat, B-3000 Leuven, Belgium
来源
ANTIBIOTICS-BASEL | 2021年 / 10卷 / 06期
关键词
chronic rhinosinusitis; recalcitrant; refractory; therapy-resistant; bacteriophages; phages; endolysins; phage therapy; PHAGE THERAPY; BIOFILMS; SERA;
D O I
10.3390/antibiotics10060675
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Chronic rhinosinusitis is a common condition affecting 5-12% of the general population worldwide. In a limited number of cases, the disease is recalcitrant to medical and surgical interventions, causing a major impact on physical, social and emotional well-being and increasing pressure on healthcare systems. Biofilm formation and dysbiosis caused by Staphylococcus aureus and Pseudomonas aeruginosa play a role in the pathogenesis of recalcitrant chronic rhinosinusitis. In these cases, a promising treatment alternative is the application of bacteriophages, which are viruses that infect and lyse bacteria. In this review, we appraise the evidence for the use of bacteriophages in the treatment of recalcitrant chronic rhinosinusitis. Additionally, (dis)advantages of bacteriophages and considerations for implementation of phage therapy in otorhinolaryngology practice will be discussed.
引用
收藏
页数:13
相关论文
共 33 条
  • [1] The Preclinical and Clinical Progress of Bacteriophages and Their Lytic Enzymes: The Parts are Easier than the Whole
    Abdelkader, Karim
    Gerstmans, Hans
    Saafan, Amal
    Dishisha, Tarek
    Briers, Yves
    [J]. VIRUSES-BASEL, 2019, 11 (02):
  • [2] Staphylococcus aureus controls interleukin-5 release in upper airway inflammation
    Bachert, C.
    Holtappels, G.
    Merabishvili, M.
    Meyer, T.
    Murr, A.
    Zhang, N.
    Van Crombruggen, K.
    Gevaert, E.
    Voelker, U.
    Broeker, B. M.
    Vaneechoutte, M.
    Schmidt, F.
    [J]. JOURNAL OF PROTEOMICS, 2018, 180 : 53 - 60
  • [3] Burrowes B, 2011, EXPERT REV ANTI-INFE, V9, P775, DOI [10.1586/ERI.11.90, 10.1586/eri.11.90]
  • [4] Synergy and Order Effects of Antibiotics and Phages in Killing Pseudomonas aeruginosa Biofilms
    Chaudhry, Waqes Nasir
    Concepcion-Acevedo, Jeniffer
    Park, Taehyun
    Andleeb, Saadia
    Bull, James J.
    Levin, Bruce R.
    [J]. PLOS ONE, 2017, 12 (01):
  • [5] Safety and efficacy of topical bacteriophage and ethylenediaminetetraacetic acid treatment of Staphylococcus aureus infection in a sheep model of sinusitis
    Drilling, Amanda
    Morales, Sandra
    Boase, Samuel
    Jervis-Bardy, Joshua
    James, Craig
    Jardeleza, Camille
    Tan, Neil Cheng-Wen
    Cleland, Edward
    Speck, Peter
    Vreugde, Sarah
    Wormald, Peter-John
    [J]. INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY, 2014, 4 (03) : 176 - 186
  • [6] Bacteriophage reduces biofilm of Staphylococcus aureus ex vivo isolates from chronic rhinosinusitis patients
    Drilling, Amanda
    Morales, Sandra
    Jardeleza, Camille
    Vreugde, Sarah
    Speck, Peter
    Wormald, Peter-John
    [J]. AMERICAN JOURNAL OF RHINOLOGY & ALLERGY, 2014, 28 (01) : 3 - 11
  • [7] Long-Term Safety of Topical Bacteriophage Application to the Frontal Sinus Region
    Drilling, Amanda J.
    Ooi, Mian L.
    Miljkovic, Dijana
    James, Craig
    Speck, Peter
    Vreugde, Sarah
    Clark, Jason
    Wormald, Peter-John
    [J]. FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2017, 7
  • [8] Fighting sinus-derived Staphylococcus aureus biofilms in vitro with a bacteriophage-derived muralytic enzyme
    Drilling, Amanda J.
    Cooksley, Clare
    Chan, Chun
    Wormald, Peter-John
    Vreugde, Sarah
    [J]. INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY, 2016, 6 (04) : 349 - 355
  • [9] Fenton Mark, 2010, Bioeng Bugs, V1, P404, DOI 10.4161/bbug.1.6.13422
  • [10] Fokkens WJ, 2020, RHINOLOGY, V58, pI